Italfarmaco Announces Exclusive Distribution Agreement with Multicare Pharma for DMD Treatment Givinostat in Brazil

Italfarmaco has entered into an agreement with Multicare for the regulatory approval and distribution of givinostat as a treatment for Duchenne ...
Grit Daily

Ten Nobel-Level Breakthroughs Position Marc Malone as Biomed Pioneer

The scientific community rarely witnesses paradigm shifts that redefine entire fields of medicine. Marc Malone’s years of ...

Investigational Drug Tinostamustine to be Included in GBM AGILE Clinical Trial for Glioblastoma

Purdue Pharma L.P. ("Purdue") has entered into an agreement to have its pipeline medication tinostamustine included in the Phase 2/3 GBM AGILE (Glioblastoma Adaptive Global Innovative Learning ...

ORYZON to Sponsor First Phelan-McDermid Syndrome (PMS) Burden of Illness Study

Study led by CureShank Aims to characterize the direct and indirect burden of PMS to patients, caregivers, and US healthcare system MADRID and ...
Nature

From immunity to tolerance through HDAC

Regulation of expression of the gene encoding interleukin 10 by the histone deacetylase HDAC11 emphasizes the ability of an antigen-presenting cell to induce immunity or tolerance in CD4 + T cells.

ORYZON to Participate in Upcoming Events in September and October

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that its management will participate at the ...